Abstract

BackgroundNeuropsychological testing is considered crucial for differential diagnosis of Alzheimer’s disease (AD) and behavioural variant frontotemporal dementia (bvFTD). In-depth neuropsychological assessment revealed specific dysfunctions in the two dementia syndromes. However, a significant overlap of cognitive impairments exists in early disease stages. We questioned whether a standard neuropsychological assessment at initial clinical presentation can delineate patients with AD versus bvFTD.MethodsIn a retrospective approach, we evaluated and compared how cognitive profiles assessed at initial clinical presentation predicted the diagnosis of later verified AD (n = 43) and bvFTD (n = 26). Additionally, the neuropsychological standard domains memory, language, visuospatial skills, executive functions, praxis and social cognition were subjected to stepwise discriminant analysis to compare their differential contribution to diagnosis.ResultsRegardless of diagnosis, a percentage of patients presented with major deterioration in a wide range of cognitive domains when compared with age-matched normative data. Only few significant differences were detected on the group level: Patients with AD were relatively more impaired in the verbal recall, verbal recognition, figure copy, and surprisingly in the executive subdomains, set shifting and processing speed whereas bvFTD was characterised by more deficits in imitation of face postures. A combination of tests for verbal recall, imitation of limb and face postures, and figure copy showed the greatest discriminatory power.ConclusionsOur results imply that the contribution of a standard neuropsychological assessment is limited for differential diagnosis of AD and bvFTD at initial presentation. In contrast to current clinical guidelines, executive functions are neither particularly nor exclusively impaired in patients with bvFTD when assessed within a standard clinical neuropsychological test battery. The significant overlap of bvFTD and AD concerning the profile of cognitive impairments questions current neuropsychological diagnostic criteria and calls for revision, regarding both the degree and the profile of cognitive deficits.

Highlights

  • Neuropsychological testing is considered crucial for differential diagnosis of Alzheimer’s disease (AD) and behavioural variant frontotemporal dementia

  • Comparison of cerebrospinal fluid (CSF) biomarker profiles between the two patient groups revealed significantly lower total amyloid-β peptide levels for the AD group, whereas total tau protein was significantly lower in the Behavioural variant frontotemporal dementia (bvFTD) group (Table 2)

  • Because researchers in previous studies have described typical cognitive profiles for AD and bvFTD pertaining to single cognitive domains and when using in-depth assessments [11,12,13,14,15,16,17,18,19,20,21], we aimed to investigate typical patterns of impairment in patients with bvFTD in a standard neuropsychological assessment employed in clinical neuropsychological routine

Read more

Summary

Introduction

Neuropsychological testing is considered crucial for differential diagnosis of Alzheimer’s disease (AD) and behavioural variant frontotemporal dementia (bvFTD). To address the issue of partly overlapping cognitive impairments in AD and bvFTD, researchers in several recent studies did in-depth investigations of neuropsychological domains such as memory, executive function, praxis and social cognition [8, 11,12,13,14,15,16,17,18,19,20,21] These studies succeeded in delineating the two diseases by investigating single cognitive domains with extensive but often time-consuming neuropsychological test batteries. It remains unclear whether a standard neuropsychological examination as usually applied in specialised memory clinics contributes to correct differentiation between AD and bvFTD and which of the aforementioned neuropsychological domains has the highest value for differential diagnosis

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call